Tornvall Per, Pernow John, Hansson Lars-Olof
Kardiologiska kliniken, Karolinska sjukhuset, Stockholm.
Lakartidningen. 2003 Aug 28;100(35):2691-3.
C-reactive protein (CRP) is a protein produced mainly in the liver upon stimulation by interleukin-6. CRP is part of the acute phase response to inflammation and plasma concentrations rise 100-1000 times in patients with for example bacterial infections. High sensitive methods have made it possible to measure and compare low CRP levels in plasma. Prospective studies have shown that increased but comparatively low plasma CRP concentrations are associated with future coronary heart disease (CHD) in healthy individuals and in patients with known CHD. Further support for an important role for CRP comes from in vitro studies that have suggested that the CRP protein is intimately and actively involved in the atherosclerotic process. This has stimulated the interest for clinical evaluation and treatment of increased plasma CRP levels.
C反应蛋白(CRP)是一种主要在肝脏中由白细胞介素-6刺激产生的蛋白质。CRP是炎症急性期反应的一部分,例如在细菌感染患者中,血浆浓度会升高100 - 1000倍。高灵敏度检测方法使测量和比较血浆中低水平的CRP成为可能。前瞻性研究表明,在健康个体和已知患有冠心病的患者中,血浆CRP浓度升高但相对较低与未来患冠心病(CHD)有关。对CRP重要作用的进一步支持来自体外研究,这些研究表明CRP蛋白密切且积极地参与动脉粥样硬化过程。这激发了对血浆CRP水平升高进行临床评估和治疗的兴趣。